Abiraterone Other names: Abiraterone Acetate

Chemical formula: C₂₄H₃₁NO  Molecular mass: 349.509 g/mol  PubChem compound: 132971

Therapeutic indications

Abiraterone is indicated for:

Metastatic castration resistant prostate cancer (mCRPC)

Population group: men, only adults (18 years old or older)

Abiraterone is indicated with prednisone or prednisolone for:

  • the treatment of metastatic castration resistant prostate cancer (mCRPC) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated
  • the treatment of mCRPC in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hormone sensitive prostate cancer (mHSPC)

Population group: men, only adults (18 years old or older)

Abiraterone is indicated with prednisone or prednisolone for the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mHSPC) in adult men in combination with androgen deprivation therapy (ADT).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Abiraterone is contraindicated in the following cases:

Pregnancy

Pregnancy

Severe hepatic impairment (Child-Pugh Class C)

Hepatic failure stage IV

Ra-223

Radium-223 dichloride

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.